Trade Mark Journal No.2026/041 9 October 2026

WO0000001927040 (10)

Office of origin: United States of America

Date of International Registration:19 May 2026
Date of designation in the UK: 19 May 2026
Image for mark 1927040 SOMA

International priority date claimed: 20 November 2025 (United States of America) (99507276)
Class 10
Transcranial medical device for detecting, monitoring, measuring, and treating cancer, cancer progression, and cancer symptoms; implantable medical device for detecting, monitoring, measuring, and treating cancer, cancer progression, and cancer symptoms; transcranial medical device for use in measuring and monitoring biometric signals, data, and symptoms; implantable medical device for use in measuring and monitoring biometric signals, data, and symptoms; medical apparatus for detecting, monitoring, measuring, and treating cancer, cancer progression, and cancer symptoms with embedded operating software in a medical device (SIMD).

Coherence Neuro Global, Inc.

Representative: Keltie LLP, No. 1 London Bridge London SE1 9BA UNITED KINGDOM